Delivery Order SPE2DB22D1202-SPE2DB24FUTB1

Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUTB1
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $3,708.60 to supply COMIRNATY COVID-19 vaccines for individuals aged 12 and up. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designations were used. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 6/7/24, 11:20 AM